Analysis of Differential BRAFV600E Mutational Status in High Aggressive Papillary Thyroid Microcarcinoma
- 26 November 2008
- journal article
- Published by Springer Science and Business Media LLC in Annals of Surgical Oncology
- Vol. 16 (2), 240-245
- https://doi.org/10.1245/s10434-008-0233-3
Abstract
Papillary thyroid cancers often occur as microcarcinoma. Some papillary thyroid microcarcinoma (PTMC) have been considered to be high aggressive according to advanced disease stages, extrathyroidal extension, and severe cervical lymph node metastasis. Although several factors are thought to predict the occurrence of aggressiveness from PTMCs, the origin of aggressiveness has been rarely studied. To answer this question, the correlation between BRAF(V600E) mutation and high aggressive PTMCs was investigated. The clinicopathological characteristic of totally 64 cases of PTMCs was investigated and the BRAF(V600E) mutational status of them was identified. BRAF(V600E) mutation was exclusively detected in PTMCs (37.5%). The data provided no correlation between the occurrence of BRAF(V600E) mutations and clinicopathological parameters, such as sex, age, and tumor-like lesions combination. The prevalence of BRAF(V600E) mutation of PTMCs with high aggressiveness (advanced disease stages, extrathyroidal extension, and nodal metastasis) was significantly higher (p < 0.05) than that of PTMCs without aggressive behavior. The BRAF(V600E) mutated PTMCs exhibited signs of higher aggressiveness than PTMCs without the mutation. BRAF(V600E) mutation may be a marker of high aggressiveness in PTMCs.Keywords
This publication has 28 references indexed in Scilit:
- Clinical and Histological Characteristics of Papillary Thyroid Microcarcinoma: Results of a Retrospective Study in 243 PatientsJournal of Clinical Endocrinology & Metabolism, 2006
- Increased Incidence of Thyroid Carcinoma in France: A True Epidemic or Thyroid Nodule Management Effects? Report from the French Thyroid Cancer CommitteeThyroid®, 2004
- Clinical Behavior and Outcome of Papillary Thyroid Cancers Smaller than 1.5 cm in Diameter: Study of 299 CasesJournal of Clinical Endocrinology & Metabolism, 2004
- BRAFV599EMutation Is the Leading Genetic Event in Adult Sporadic Papillary Thyroid CarcinomasJournal of Clinical Endocrinology & Metabolism, 2004
- Mutations of the BRAF Gene in Papillary Thyroid Carcinoma in a Korean PopulationYonsei Medical Journal, 2004
- BRAF Mutations in Thyroid Tumors Are Restricted to Papillary Carcinomas and Anaplastic or Poorly Differentiated Carcinomas Arising from Papillary CarcinomasJournal of Clinical Endocrinology & Metabolism, 2003
- BRAF mutations in papillary carcinomas of the thyroidOncogene, 2003
- Clinical Implication of Hot SpotBRAFMutation, V599E, in Papillary Thyroid CancersJournal of Clinical Endocrinology & Metabolism, 2003
- Papillary microcarcinoma of the thyroid—Prognostic significance of lymph node metastasis and multifocalityCancer, 2003
- Extracapsular invasion of lymph node metastasisCancer, 1999